PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:06 AM ET

Sponsor Check › Person

WO
No photo found yet (own website and image search run after this page is viewed)

Walter Ogier

Named as an officer, director or promoter on SEC Form D filings · MA, CA, MI · Feb 22, 2011 → May 17, 2019

4deals (issuers)
$132.1Mreported sold
138investors
12Form D filings
2011–2019years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:02 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Walter Ogier is listed as an executive officer and director on 12 SEC Form D filings by 4 issuers between Aug 2009 and Oct 2026: Eledon Pharmaceuticals, Inc. (Irvine, CA — biotechnology — 2020–2024; $108.1M reported sold to 38 investors), Acetylon Pharmaceuticals, Inc. (Boston, MA — pharmaceuticals — 2009–2011; $14M reported sold to 38 investors), Thetis Pharmaceuticals LLC (Deep River, CT — pharmaceuticals — 2017–2026; $5.67M reported sold to 52 investors) and Anelixis Therapeutics, Inc. (Cambridge, MA — biotechnology — 2018–2019; $4.29M reported sold to 10 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $132.1M sold in total.

Listed alongside Steven Perrin (5 shared filings), Dennis Willson (4 shared filings), Frank C Sciavolino (4 shared filings), Gary F Mathias (4 shared filings), Bruce Downey (3 shared filings) and 21 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Walter. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 12 public filings for Walter Ogier and found 14 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Walter Ogier has not run yet — it is joining a line of 46,900 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Walter Ogier..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

14 differences found between the filings for Walter Ogier — 1 worth asking about (compared 12 filings on Oct 24, 2026)

Note · Aug 15, 2011

Walter Ogier appears on 1 deal that stopped filing before reaching its target

Acetylon Pharmaceuticals, Inc. (last filing Aug 15, 2011; $13,988,109 sold of $30,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Acetylon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jul 24, 2009 – Oct 13, 2026

4 Form Ds were filed more than 15 days after the first sale

Form D filed 61 days after the first sale — Thetis Pharmaceuticals LLC · Form D filed 17 days after the first sale — Eledon Pharmaceuticals, Inc. · Form D filed 17 days after the first sale — Anelixis Therapeutics, Inc. · Form D filed 17 days after the first sale — Acetylon Pharmaceuticals, Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Oct 13, 2026 ↗Thetis Pharmaceuticals LLC — PartnerFacts page ↗Form D · May 22, 2023 ↗Eledon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jul 24, 2009 – May 23, 2024

9 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Eledon Pharmaceuticals, Inc. (latest filing May 23, 2024) · No amendment in the last 12 months on an offering that may still be open — Eledon Pharmaceuticals, Inc. (latest filing May 22, 2023) · No amendment in the last 12 months on an offering that may still be open — Thetis Pharmaceuticals LLC (latest filing Jul 11, 2022) · No amendment in the last 12 months on an offering that may still be open — Anelixis Therapeutics, Inc. (latest filing May 17, 2019) · No amendment in the last 12 months on an offering that may still be open — Thetis Pharmaceuticals LLC (latest filing Aug 7, 2018) · and 4 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · May 23, 2024 ↗Eledon Pharmaceuticals, Inc. — PartnerFacts page ↗Form D · May 22, 2023 ↗Form D · Jul 11, 2022 ↗
Sources
Note · Feb 22, 2011 – Aug 15, 2011

Walter Ogier's role changed at Acetylon Pharmaceuticals, Inc.: director → executive officer, director

The Feb 22, 2011 filing lists Walter Ogier as director; the Aug 15, 2011 Form D/A lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 22, 2011 ↗Form D/A · Aug 15, 2011 ↗Walter Ogier — PartnerFacts page ↗Acetylon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Aug 10, 2009 – Feb 22, 2011

Walter Ogier's role changed at Acetylon Pharmaceuticals, Inc.: executive officer, director → director

The Aug 10, 2009 filing lists Walter Ogier as executive officer, director; the Feb 22, 2011 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Aug 10, 2009 ↗Form D · Feb 22, 2011 ↗Walter Ogier — PartnerFacts page ↗Acetylon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 27, 2016 – Jan 17, 2017

Offering amount changed between filings — Thetis Pharmaceuticals LLC

The Jun 27, 2016 filing says $5,000,059 offered; the Jan 17, 2017 Form D/A says $8,000,062.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jun 27, 2016 ↗Form D/A (later) · Jan 17, 2017 ↗Thetis Pharmaceuticals LLC — PartnerFacts page ↗
Sources
Note · Feb 22, 2011 – Aug 15, 2011

Offering amount lowered between filings — Acetylon Pharmaceuticals, Inc.

The Feb 22, 2011 filing says $30,000,000 offered; the Aug 15, 2011 Form D/A says $27,625,625.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Feb 22, 2011 ↗Form D/A (later) · Aug 15, 2011 ↗Acetylon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Aug 10, 2009 – Feb 22, 2011

Walter Ogier is written 2 different ways on the filings

listed as "Walter C. Ogier" on 2 filings (from Aug 10, 2009), and "Walter Ogier" on 10 filings (from Feb 22, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Aug 10, 2009 ↗Form D · Feb 22, 2011 ↗Walter Ogier — PartnerFacts page ↗
Sources
Note · Sep 25, 2020 – May 22, 2023

Reported revenue range changed between filings — Eledon Pharmaceuticals, Inc.

"Decline to Disclose" (Sep 25, 2020); then "No Revenues" (May 22, 2023).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Sep 25, 2020 ↗Form D · May 22, 2023 ↗Eledon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Aug 10, 2009 – Feb 22, 2011

Reported revenue range changed between filings — Acetylon Pharmaceuticals, Inc.

"No Revenues" (Aug 10, 2009); then "Decline to Disclose" (Feb 22, 2011).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Aug 10, 2009 ↗Form D · Feb 22, 2011 ↗Acetylon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jul 11, 2022 – Oct 13, 2026

Address moved from Quaker Hill, CT to Deep River, CT — Thetis Pharmaceuticals LLC

The people listed on the Jul 11, 2022 filing give Quaker Hill, CT; on the Oct 13, 2026 filing they give Deep River, CT.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 11, 2022 ↗Form D · Oct 13, 2026 ↗Thetis Pharmaceuticals LLC — PartnerFacts page ↗
Sources
Note · Aug 7, 2018 – Jul 11, 2022

Address moved from Waterford, CT to Quaker Hill, CT — Thetis Pharmaceuticals LLC

The people listed on the Aug 7, 2018 filing give Waterford, CT; on the Jul 11, 2022 filing they give Quaker Hill, CT.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Aug 7, 2018 ↗Form D · Jul 11, 2022 ↗Thetis Pharmaceuticals LLC — PartnerFacts page ↗
Sources
Note · Jun 27, 2016 – Jan 17, 2017

Address moved from West Hartford, CT to Waterford, CT — Thetis Pharmaceuticals LLC

The people listed on the Jun 27, 2016 filing give West Hartford, CT; on the Jan 17, 2017 filing they give Waterford, CT.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jun 27, 2016 ↗Form D/A · Jan 17, 2017 ↗Thetis Pharmaceuticals LLC — PartnerFacts page ↗
Sources
Note · Aug 10, 2009 – Oct 13, 2026

Walter Ogier is listed with 3 different address states: MA, CA, MI

MA on 7 filings (Aug 10, 2009 to May 17, 2019); CA on 3 filings (Sep 25, 2020 to May 23, 2024); MI on 2 filings (Jul 11, 2022 to Oct 13, 2026).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Aug 10, 2009 ↗Form D · Sep 25, 2020 ↗Form D · Jul 11, 2022 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 11 offerings report sales commissions totalling $7,268,732; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 13, 2026 D
Thetis Pharmaceuticals LLC
File 021-600869
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
May 23, 2024 D
Eledon Pharmaceuticals, Inc.
File 021-514042
$1,617,174$0$0Leerink Partners LLC BrokerCheck CRD 39011 ↗
Noble Capital Markets, Inc. BrokerCheck CRD 15768 ↗		EDGAR ↗
May 22, 2023 D
Eledon Pharmaceuticals, Inc.
File 021-482292
$1,227,961$0$0SVB Securities LLC BrokerCheck CRD 39011 ↗
Noble Capital Markets, Inc. BrokerCheck CRD 15768 ↗		EDGAR ↗
Jul 11, 2022 D
Thetis Pharmaceuticals LLC
File 021-451818
$0$0$0None listed on this filingEDGAR ↗
Sep 25, 2020 D
Eledon Pharmaceuticals, Inc.
File 021-376405
$4,123,597$0$0SVB Leerink LLC BrokerCheck CRD 39011 ↗
Noble Capital Markets, Inc. BrokerCheck CRD 15768 ↗		EDGAR ↗
May 17, 2019 D
Anelixis Therapeutics, Inc.
File 021-339827
$100,000$0$0Noble Capital Markets BrokerCheck CRD 15768 ↗EDGAR ↗
Aug 7, 2018 D
Thetis Pharmaceuticals LLC
File 021-318610
$0$0$0
No payments other than ordinary course employment compensation is being paid to officers or managers.
None listed on this filingEDGAR ↗
Apr 25, 2018 D
Anelixis Therapeutics, Inc.
File 021-310988
$0$0$0None listed on this filingEDGAR ↗
Jan 17, 2017 D/A
Thetis Pharmaceuticals LLC
File 021-265832
$200,000 (est.)$0$0
No payments other than ordinary course employment compensation is being paid to officers or managers.
Fairport Capital, Inc. BrokerCheck CRD 15034 ↗
via Fairport Capital, Inc. (CRD 15034 ↗)
EDGAR ↗
Aug 15, 2011 D/A
Acetylon Pharmaceuticals, Inc.
File 021-155652
$0$0$0None listed on this filingEDGAR ↗
Aug 10, 2009 D
Acetylon Pharmaceuticals, Inc.
File 021-133465
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Walter Ogier on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

TP
Pharmaceuticals

Thetis Pharmaceuticals LLC

Deep River, CT · Jan 17, 2017 → Oct 13, 2026 · 4 filings
  • Oct 13, 2026 · D · $560,300 sold of $1,000,000 · 10 investors · min. No minimum reported · role: Director (Manager) EDGAR ↗
  • Jul 11, 2022 · D · $1,098,320 sold of $2,000,000 · 9 investors · min. $10,000 · role: Director (Manager) EDGAR ↗
  • Aug 7, 2018 · D · $795,800 sold of $2,100,000 · 8 investors · min. No minimum reported · role: Director (Manager) EDGAR ↗
  • Jan 17, 2017 · D/A · $4,105,495 sold of $8,000,062 · 52 investors · min. No minimum reported · role: Director (Manager) EDGAR ↗

Raised $5.67M from 52 investors (100% of the $1M target) as of the latest filing. Walter is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EP
Biotechnology

Eledon Pharmaceuticals, Inc.

Irvine, CA · Sep 25, 2020 → May 23, 2024 · 3 filings
  • May 23, 2024 · D · $49,999,010 sold of Indefinite · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 22, 2023 · D · $35,000,000 sold of Indefinite · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 25, 2020 · D · $108,144,151 sold of $108,144,151 · 35 investors · min. $498 · role: Director EDGAR ↗

Raised $108.1M from 38 investors as of the latest filing. Walter is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

Anelixis Therapeutics, Inc.

Cambridge, MA · Apr 25, 2018 → May 17, 2019 · 2 filings
  • May 17, 2019 · D · $1,000,000 sold of $6,000,000 · 10 investors · min. $50,000 · role: Director EDGAR ↗
  • Apr 25, 2018 · D · $2,574,131 sold of $4,500,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $4.29M from 10 investors (71% of the $6M target) as of the latest filing. Walter is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals

Acetylon Pharmaceuticals, Inc.

Boston, MA · Aug 10, 2009 → Aug 15, 2011 · 3 filings
  • Aug 15, 2011 · D/A · $13,988,109 sold of $27,625,625 · 38 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 22, 2011 · D · $12,400,000 sold of $30,000,000 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 10, 2009 · D · $7,250,000 sold of $8,000,000 · 11 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗

Raised $14M from 38 investors (51% of the $27.6M target) as of the latest filing. Walter is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Walter 26

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Perrin

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

FS
No photo found yet (own website and image search run after this page is viewed)
Person

Frank C Sciavolino

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

Gary F Mathias

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Willson

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Walter Ogier. Their page shows their other deals.

KA
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Anderson

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Kenneth Anderson is on 6 issuers in total — a repeat sponsor. Their page lists every one.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Downey

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Walter Ogier. Their page shows their other deals.

EP
No photo found yet (own website and image search run after this page is viewed)
Person

Elena Prokupets

Director · 3 shared filings (1 issuer) · also on 4 other issuers

Elena Prokupets is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Bradner

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Walter Ogier. Their page shows their other deals.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Keith A. Katkin

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Walter Ogier. Their page shows their other deals.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

David-Alexandre Gros

Executive Officer, Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Walter Ogier. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

John McBride

Director · 3 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Marc Cohen

Executive Officer, Director · 3 shared filings (1 issuer) · also on 9 other issuers

Marc Cohen is on 10 issuers in total — a repeat sponsor. Their page lists every one.

GL
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Lyons

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Walter Ogier. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Maeve McNally

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Augie Nieto

Director · 2 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

June Lee

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Walter Ogier. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jan Hillson

Director · 2 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Bryan Smith

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Little

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Wurzer

Director · 2 shared filings (1 issuer) · also on 9 other issuers

David Wurzer is on 10 issuers in total — a repeat sponsor. Their page lists every one.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

James Robinson

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Walter Ogier. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Cynthia Green

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Walter Ogier. Their page shows their other deals.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Allan Kirk

Director · 1 shared filing (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jon Kuwahara

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Walter Ogier. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Fabio Cataldi

Director · 1 shared filing (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David Cook

Director · 1 shared filing (1 issuer)

Listed on the same filings as Walter Ogier. Their page shows their other deals.

The team behind the deals

Same business address

33 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Walter Ogier by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Walter Ogier is listed on: none on file. No website or social profile named in Eledon Pharmaceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #98,602 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Irvine, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗California — find the county court ↗Los Angeles Superior Court case search ↗Michigan state courts — find the court ↗Connecticut Judicial Branch case look-up ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗California Secretary of State business search ↗Michigan Secretary of State business search ↗Connecticut Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Walter Ogier appears on a new Form D, or when a court case or SEC action is matched to them. See plans →